Lodestar

MASS

908 Devices Inc.
NasdaqLaboratory Analytical InstrumentsLatest fiscal year ended Dec 31, 2025

908 Devices Inc. reported revenue of $56.20M in its most recent fiscal year, up 17.7% on the year before. It kept 34.7% of that as net income, and generated -$24.64M of free cash flow. Figures below are compared against other companies classified under Laboratory Analytical Instruments.

Grades vs. industry

Growth
B+71/100
Ranked against 20 peers using 3 metrics.
Profitability
C+58/100
Ranked against 17 peers using 7 metrics.

Growth

MetricCompanyIndustry medianRank
Revenue growth (YoY)
Latest fiscal year revenue vs. the year before.
17.7%2.9%3 / 20
Revenue growth (3y)
Annualized revenue growth over three fiscal years.
6.2%2.2%9 / 20
Revenue growth (5y)
Annualized revenue growth over five fiscal years.
15.9%10.8%7 / 20
EPS growth (YoY)
Diluted EPS vs. the prior fiscal year.
Not reported-2.7%—
EPS growth (3y)
Annualized diluted EPS growth over three fiscal years.
Not reported——
EPS growth (5y)
Annualized diluted EPS growth over five fiscal years.
Not reported4.7%—
Free cash flow growth (YoY)
Operating cash flow less capital expenditure, vs. prior year.
Not reported-9.4%—
Free cash flow growth (3y)
Annualized free cash flow growth over three fiscal years.
Not reported4.1%—

top third of peersmiddle thirdbottom third. Rank 1 is always best — for debt and payout ratios that means the lowest figure, not the highest.

“Not reported” means the company did not tag this figure in its filing, not that the value is zero. Rankings are hidden where fewer than 5 classified peers reported the metric, and compare against a broad industry code rather than close competitors.

Profitability

MetricCompanyIndustry medianRank
Gross margin
Gross profit as a share of revenue. Often unreported.
50.6%51.1%10 / 17
Operating margin
Operating income as a share of revenue.
-70.1%-14.8%12 / 18
Net margin
Net income as a share of revenue.
34.7%-6.8%1 / 19
Free cash flow margin
Free cash flow as a share of revenue.
-43.9%3.9%13 / 18
Return on equity
Net income divided by shareholder equity.
13.6%-9.5%4 / 19
Return on assets
Net income divided by total assets.
10.3%-4.5%4 / 21
Return on invested capital
After-tax operating profit over debt plus equity less cash.
-42.6%-13.8%13 / 18

top third of peersmiddle thirdbottom third. Rank 1 is always best — for debt and payout ratios that means the lowest figure, not the highest.

“Not reported” means the company did not tag this figure in its filing, not that the value is zero. Rankings are hidden where fewer than 5 classified peers reported the metric, and compare against a broad industry code rather than close competitors.

Financial health

MetricCompanyIndustry medianRank
Debt to equity
Total debt divided by shareholder equity.
Not reported0.50x—
Current ratio
Current assets over current liabilities.
4.24x2.84x9 / 21
Quick ratio
Current assets excluding inventory, over current liabilities.
3.86x2.11x9 / 21
Interest coverage
Operating income divided by interest expense.
Not reported0.96x—
Net debt to EBITDA
Net debt over derived EBITDA. EBITDA is not a GAAP tag; it is computed.
Not reported0.64x—

top third of peersmiddle thirdbottom third. Rank 1 is always best — for debt and payout ratios that means the lowest figure, not the highest.

“Not reported” means the company did not tag this figure in its filing, not that the value is zero. Rankings are hidden where fewer than 5 classified peers reported the metric, and compare against a broad industry code rather than close competitors.

Insider activity

Trades reported by officers, directors and 10% shareholders on SEC Form 4. None of the last 32 reported transactions were open-market purchases — grants, option exercises and sales make up the majority of insider filings at most companies.

DateInsiderTransactionSharesPriceValue
Oct 7, 2026
Brown Christopher D.
Director
Open-market sale30,000$11.89$356.7K
Oct 7, 2026
Brown Christopher D.
Director
Option exercise60,000$1.75$105.0K
Oct 7, 2026
Brown Christopher D.
Director
Option exercise(derivative)60,000$0.00$0.00
Oct 6, 2026
Griffith Joseph H. IV
Chief Financial Officer
Open-market sale5,000$13.03$65.2K
Sep 29, 2026
AWM Investment Company, Inc.
10% owner
Open-market sale18,000$11.52$207.3K
Sep 24, 2026
AWM Investment Company, Inc.
10% owner
Open-market sale24,000$11.36$272.6K
Sep 23, 2026
AWM Investment Company, Inc.
10% owner
Open-market sale1,000$11.25$11.3K
Sep 17, 2026
Kenneweg John
SVP, Sales & Product Marketing
Open-market sale5,257$10.22$53.7K
Sep 17, 2026
Kenneweg John
SVP, Sales & Product Marketing
Option exercise5,257$0.96$5.0K
Sep 17, 2026
Kenneweg John
SVP, Sales & Product Marketing
Option exercise(derivative)5,257$0.00$0.00
Sep 16, 2026
Kenneweg John
SVP, Sales & Product Marketing
Open-market sale21,399$10.11$216.3K
Sep 16, 2026
Kenneweg John
SVP, Sales & Product Marketing
Option exercise21,399$0.96$20.5K
Sep 16, 2026
Kenneweg John
SVP, Sales & Product Marketing
Option exercise(derivative)21,399$0.00$0.00
Sep 15, 2026
Kenneweg John
SVP, Sales & Product Marketing
Open-market sale1,000$10.00$10.0K
Sep 15, 2026
Kenneweg John
SVP, Sales & Product Marketing
Option exercise1,000$0.96$960.00
Sep 15, 2026
Kenneweg John
SVP, Sales & Product Marketing
Option exercise(derivative)1,000$0.00$0.00
Sep 2, 2026
Brown Christopher D.
Director
Open-market sale30,000$10.58$317.4K
Aug 25, 2026
Griffith Joseph H. IV
Chief Financial Officer
Open-market sale11,459$10.95$125.5K
Aug 21, 2026
AWM Investment Company, Inc.
10% owner
Open-market sale41,578$10.61$441.2K
Aug 20, 2026
AWM Investment Company, Inc.
10% owner
Open-market sale8,422$10.52$88.6K
Aug 17, 2026
Knopp Kevin J.
President and CEO
Open-market sale20,000$10.35$207.0K
Aug 13, 2026
Knopp Kevin J.
President and CEO
Open-market sale7,622$10.06$76.7K
Aug 12, 2026
Knopp Kevin J.
President and CEO
Open-market sale2,747$10.07$27.7K
Aug 11, 2026
Knopp Kevin J.
President and CEO
Open-market sale115,748$9.83$1.14M
Aug 11, 2026
Knopp Kevin J.
President and CEO
Open-market sale30,170$10.16$306.5K

A dash under price or value means none was reported, which is normal for grants and gifts — it does not mean the shares were free. Option exercises and awards are compensation arriving on a schedule, not a judgement about the stock.

Annual financials

Fiscal year202520242023202220212020
Revenue$56.20M$47.75M$50.23M$46.85M$42.21M$26.89M
Gross profit$28.42M$24.50M$25.32M$26.02M$23.23M$14.92M
Operating income-$39.42M-$57.39M-$42.76M-$35.38M-$22.07M-$5.82M
Net income$19.49M-$72.21M-$36.40M-$33.56M-$22.17M-$12.82M
EPS (diluted)$0.54-$2.12-$1.13-$1.07-$0.79n/c
Operating cash flow-$23.69M-$30.25M-$25.06M-$20.93M-$29.08M$4.13M
Capital expenditure$955.0K$602.0K$2.04M$2.04M$737.0K$9.0K
Free cash flow-$24.64M-$30.85M-$27.10M-$22.98M-$29.82M$4.12M
Total assets$190.07M$159.48M$202.98M$242.59M$260.91M$178.83M
Shareholder equity$143.70M$114.59M$165.49M$190.60M$214.60M$139.04M
Total debt———$15.00M$15.00M$14.83M
Cash$70.52M$44.03M$121.04M$188.42M$224.07M$159.23M

A dash means the figure was not tagged in that year’s filing. It does not mean zero. Figures reflect the most recent filing covering each period, so restated years show their restated values.

n/c marks per-share figures that are not comparable. Companies report each year as their filings stated it, and an annual report restates only its two prior years — so after a stock split, older years remain on the pre-split share count. Totals above are unaffected.

Source

Figures come from 908 Devices Inc.’s filings with the SEC, as submitted in XBRL. The most recent annual figures are from a 10-K filed Mar 9, 2026. View filings on EDGAR.

Not financial advice. This page presents figures reported to the SEC and compares them with other companies sharing an industry classification. It is not a recommendation to buy or sell anything, and the grades cannot capture everything that matters about a business. Industry classifications are coarse, filings are self-reported, and some figures are missing or understated where companies tag them in ways this site does not match. Do your own research.